Get 20% lifetime commission for referring investors to digrin.com
here.
Protara Therapeutics, Inc. (TARA) Financials
TARA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 176.1 million | 14.8 million |
| March 31, 2026 | 191.9 million | 10.7 million |
| Dec. 31, 2025 | 209.5 million | 13.1 million |
| Sept. 30, 2025 | 144.6 million | 12.3 million |
TARA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -14.4 million | 1.4 million |
| March 31, 2026 | -21.3 million | 1.4 million |
| Dec. 31, 2025 | -17.0 million | 1.0 million |
| Sept. 30, 2025 | -12.5 million | 1.0 million |
TARA Net Income
No data available :(
TARA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 17.1 million | - | 2.7 million |
| March 31, 2026 | 135.8 million | 1.8 million | 1.3 million |
| Dec. 31, 2025 | 155.6 million | - | 3.4 million |
| Sept. 30, 2025 | 132.7 million | - | 3.7 million |
TARA Shares Outstanding
TARA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 332000 | 17.0 million | 6.4 million | - |
| March 31, 2026 | - | 13.5 million | 6.1 million | - |
| Dec. 31, 2025 | 24000 | 13.1 million | 6.0 million | - |
| Sept. 30, 2025 | 4000 | 9.6 million | 5.2 million | - |
TARA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 90000 |
| Dec. 31, 2025 | - | 93000 |
| Sept. 30, 2025 | - | 88000 |
TARA
Price: $3.94
52 week price:
Earnings Per Share: -1.36 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2909
Market Capitalization: 234.6 million